miR-199a-5p inhibits monocyte/macrophage differentiation by targeting the activin a type 1B receptor gene and finally reducing C/EBPα expression

Journal of Leukocyte Biology

Volumn 96, Issue 6, 2014, Pages 1023-1035

  Lin, Hai Shuang ^a   Gong, Jia Nan ^a   Su, Rui ^a   Chen, Ming Tai ^a   Song, Li ^a   Shen, Chao ^a   Wang, Fang ^a   Ma, Yan Ni ^a   Zhao, Hua Lu ^a   Yu, Jia ^a   Li, Wei Wei ^b   Huang, Li Xia ^b   Xu, Xin Hua ^c   Zhang, Jun Wu ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c Taizhou Cancer Hospital   (China)

Author keywords

Cell proliferation and cell cycle; Phosphorylation of Smad2 3; PU.1; TGF signaling pathway

Indexed keywords

ACTIVIN A; ACTIVIN TYPE 1B RECEPTOR; CCAAT ENHANCER BINDING PROTEIN ALPHA; MICRORNA; MICRORNA 199A 5P; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG; ACTIVIN RECEPTOR 1; ACVR1B PROTEIN, HUMAN; MIRN199 MICRORNA, HUMAN; ONCOPROTEIN; PROTO-ONCOGENE PROTEIN SPI-1; RETINOBLASTOMA PROTEIN; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HL 60 CELL LINE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MONOCYTE MACROPHAGE PRECURSOR CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RECEPTOR GENE; UPREGULATION; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; CFU COUNTING; CYTOLOGY; DRUG EFFECTS; FETUS BLOOD; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MACROPHAGE; METABOLISM; MONOCYTE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING; REPORTER GENE; RNA INTERFERENCE; TUMOR CELL LINE;

ACTIVIN RECEPTORS, TYPE I; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE, TUMOR; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; FETAL BLOOD; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REPORTER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HL-60 CELLS; HUMANS; MACROPHAGES; MICRORNAS; MONOCYTES; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE; RNA, SMALL INTERFERING; SMAD2 PROTEIN; TRANS-ACTIVATORS; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 84914142033     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1A0514-240R     Document Type: Article

References (55)

1. Kerenyi, M. A., Orkin, S. H. (2010) Networking erythropoiesis. J. Exp. Med. 207, 2537-2541.
2. Suh, N., Blelloch, R. (2011) Small RNAs in early mammalian development: from gametes to gastrulation. Development 138, 1653-1661.
3. Kawasaki, H., Taira, K. (2004) MicroRNA-196 inhibits HOXB8 expression in myeloid differentiation of HL60 cells. Nucleic Acids Symp. Ser. (Oxf). 48, 211-212.
4. Rosa, A., Ballarino, M., Sorrentino, A., Sthandier, O., De Angelis, F. G., Marchioni, M., Masella, B., Guarini, A., Fatica, A., Peschle, C., Bozzoni, I. (2007) The interplay between the master transcription factor PU. 1 and miR-424 regulates human monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. USA 104, 19849-19854.
5. Forrest, A. R., Kanamori-Katayama, M., Tomaru, Y., Lassmann, T., Ninomiya, N., Takahashi, Y., de Hoon, M. J., Kubosaki, A., Kaiho, A., Suzuki, M., Yasuda, J., Kawai, J., Hayashizaki, Y., Hume, D. A., Suzuki, H. (2010) Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 24, 460-466.
6. Salvatori, B., Iosue, I., Mangiavacchi, A., Loddo, G., Padula, F., Chiaretti, S., Peragine, N., Bozzoni, I., Fazi, F., Fatica, A. (2012) The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells. Cell Death Dis. 3, e413.
7. Wang, X. S., Gong, J. N., Yu, J., Wang, F., Zhang, X. H., Yin, X. L., Tan, Z. Q., Luo, Z. M., Yang, G. H., Shen, C., Zhang, J. W. (2012) MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood 119, 4992-5004.
8. Wang, F., Wang, X. S., Yang, G. H., Zhai, P. F., Xiao, Z., Xia, L. Y., Chen, L. R., Wang, Y., Wang, X. Z., Bi, L. X., Liu, N., Yu, Y., Gao, D., Huang, B. T., Wang, J., Zhou, D. B., Gong, J. N., Zhao, H. L., Bi, X. H., Yu, J., Zhang, J. W. (2012) Down-regulation of miR-29a and miR-142-3p and their diagnostic implication in human acute myeloid leukemia. Mol. Bio. Rep. 46, 505-508.
9. He, M., Wang, Q. Y., Yin, Q. Q., Tang, J., Lu, Y., Zhou, C. X., Duan, C. W., Hong, D. L., Tanaka, T., Chen, G. Q., Zhao, Q. (2013) HIF-1alpha downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation. Cell Death Differ. 20, 408-418.
10. Fu, G., Ye, G., Nadeem, L., Ji, L., Manchanda, T., Wang, Y., Zhao, Y., Qiao, J., Wang, Y. L., Lye, S., Yang, B. B., Peng, C. (2013) MicroRNA-376c impairs transforming growth factor-beta and nodal signaling to promote trophoblast cell proliferation and invasion. Hypertension 61, 864-872.
11. Duggal, G., Heindryckx, B., Warrier, S., O’Leary, T., Van der Jeught, M., Lierman, S., Vossaert, L., Deroo, T., Deforce, D., Chuva de Sousa Lopes, S. M., De Sutter, P. (2013) Influence of activin A supplementation during human embryonic stem cell derivation on germ cell differentiation potential. Stem Cells Dev. 22, 3141-3155.
12. Feng, X. H., Derynck, R. (2005) Specificity and versatility in TGF-beta signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659-693.
13. Alarcon, C., Zaromytidou, A. I., Xi, Q., Gao, S., Yu, J., Fujisawa, S., Barlas, A., Miller, A. N., Manova-Todorova, K., Macias, M. J., Sapkota, G., Pan, D., Massague, J. (2009) Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139, 757-769.
14. Shiozaki, M., Sakai, R., Tabuchi, M., Nakamura, T., Sugino, K., Sugino, H., Eto, Y. (1992) Evidence for the participation of endogenous activin A/erythroid differentiation factor in the regulation of erythropoiesis. Proc. Natl. Acad. Sci. USA 89, 1553-1556.
15. Wang, Q., Huang, Z., Xue, H., Jin, C., Ju, X. L., Han, J. D., Chen, Y. G. (2008) MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 111, 588-595.
16. Jacobsen, S. E., Ruscetti, F. W., Ortiz, M., Gooya, J. M., Keller, J. R. (1994) The growth response of Lin_Thy-1_hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors. Exp. Hematol. 22, 985-989.
17. Drexler, H. G., Meyer, C., Zaborski, M., Uphoff, C. C., Quentmeier, H. (1998) Growth-inhibitory effects of transforming growth factor-beta 1 on myeloid leukemia cell lines. Leuk. Res. 22, 927-938.
18. De Marchis, M. L., Ballarino, M., Salvatori, B., Puzzolo, M. C., Bozzoni, I., Fatica, A. (2009) A new molecular network comprising PU. 1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells. Leukemia 23, 856-862.
19. Blount, A. L., Vaughan, J. M., Vale, W. W., Bilezikjian, L. M. (2008) A Smad-binding element in intron 1 participates in activin-dependent regulation of the follistatin gene. J. Biol. Chem. 283, 7016-7026.
20. Giampieri, S., Manning, C., Hooper, S., Jones, L., Hill, C. S., Sahai, E. (2009) Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat. Cell Biol. 11, 1287-1296.
21. Yang, G. H., Wang, F., Yu, J., Wang, X. S., Yuan, J. Y., Zhang, J. W. (2009) MicroRNAs are involved in erythroid differentiation control. J. Cell. Biochem. 107, 548-556.
22. Yin, G., Chen, R., Alvero, A. B., Fu, H. H., Holmberg, J., Glackin, C., Rutherford, T., Mor, G. (2010) TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214. Oncogene 29, 3545-3553.
23. Friedman, A. D. (2007) Transcriptional control of granulocyte and monocyte development. Oncogene 26, 6816-6828.
24. Poon, G. M. (2012) DNA binding regulates the self-association of the ETS domain of PU. 1 in a sequence-dependent manner. Biochemistry 51, 4096-4107.
25. Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L., Arteaga, C. L. (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803-36810.
26. Decker, T., Schneller, F., Hipp, S., Miething, C., Jahn, T., Duyster, J., Peschel, C. (2002) Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia 16, 327-334.
27. Wang, L., Wang, J., Blaser, B. W., Duchemin, A. M., Kusewitt, D. F., Liu, T., Caligiuri, M. A., Briesewitz, R. (2007) Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia. Blood 110, 2075-2083.
28. Schotte, D., Pieters, R., Den Boer, M. L. (2012) MicroRNAs in acute leukemia: from biological players to clinical contributors. Leukemia 26, 1-12.
29. Alexander, M. S., Kawahara, G., Motohashi, N., Casar, J. C., Eisenberg, I., Myers, J. A., Gasperini, M. J., Estrella, E. A., Kho, A. T., Mitsuhashi, S., Shapiro, F., Kang, P. B., Kunkel, L. M. (2013) MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation. Cell Death Differ. 20, 1194-1208.
30. Pencheva, N., Tran, H., Buss, C., Huh, D., Drobnjak, M., Busam, K., Tavazoie, S. F. (2012) Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151, 1068-1082.
31. Chan, Y. C., Roy, S., Huang, Y., Khanna, S., Sen, C. K. (2012) The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway. J. Biol. Chem. 287, 41032-41043.
32. Xu, N., Zhang, J., Shen, C., Luo, Y., Xia, L., Xue, F., Xia, Q. (2012) Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. Biochem. Biophys. Res. Commun. 423, 826-831.
33. Thisse, B., Stoetzel, C., Gorostiza-Thisse, C., Perrin-Schmitt, F. (1988) Sequence of the twist gene and nuclear localization of its protein in endomesodermal cells of early Drosophila embryos. EMBO J. 7, 2175-2183.
34. Lee, Y. B., Bantounas, I., Lee, D. Y., Phylactou, L., Caldwell, M. A., Uney, J. B. (2009) Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res. 37, 123-128.
35. Pham, T. H., Benner, C., Lichtinger, M., Schwarzfischer, L., Hu, Y., Andreesen, R., Chen, W., Rehli, M. (2012) Dynamic epigenetic enhancer signatures reveal key transcription factors associated with monocytic differentiation states. Blood 119, e161-e171.
36. Fujita, S., Ito, T., Mizutani, T., Minoguchi, S., Yamamichi, N., Sakurai, K., Iba, H. (2008) miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 378, 492-504.
37. Fukao, T., Fukuda, Y., Kiga, K., Sharif, J., Hino, K., Enomoto, Y., Kawamura, A., Nakamura, K., Takeuchi, T., Tanabe, M. (2007) An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129, 617-631.
38. Utsugisawa, T., Moody, J. L., Aspling, M., Nilsson, E., Carlsson, L., Karlsson, S. (2006) A road map toward defining the role of Smad signaling in hematopoietic stem cells. Stem Cells 24, 1128-1136.
39. Yook, J. Y., Kim, M. J., Son, M. J., Lee, S., Nam, Y., Han, Y. M., Cho, Y. S. (2011) Combinatorial activin receptor-like kinase/Smad and basic fibroblast growth factor signals stimulate the differentiation of human embryonic stem cells into the cardiac lineage. Stem Cells Dev. 20, 1479-1490.
40. Takagi, K., Kawaguchi, Y., Kawamoto, M., Ota, Y., Tochimoto, A., Gono, T., Katsumata, Y., Takagi, M., Hara, M., Yamanaka, H. (2011) Activation of the activin A-ALK-Smad pathway in systemic sclerosis. J. Autoimmun. 36, 181-188.
41. Wotton, D., Lo, R. S., Lee, S., Massague, J. (1999) A Smad transcriptional corepressor. Cell 97, 29-39.
42. Massague, J. (2008) TGFbeta in cancer. Cell 134, 215-230.
43. Pan, Z., Hetherington, C. J., Zhang, D. E. (1999) CCAAT/enhancerbinding protein activates the CD14 promoter and mediates transforming growth factor beta signaling in monocyte development. J. Biol. Chem. 274, 23242-23248.
44. Johnson, P. F. (2005) Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J. Cell Sci. 118, 2545-2555.
45. Nerlov, C. (2007) The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol. 17, 318-324.
46. Smith, L. T., Hohaus, S., Gonzalez, D. A., Dziennis, S. E., Tenen, D. G. (1996) PU. 1 (Spi-1) and C/EBP alpha regulate the granulocyte colonystimulating factor receptor promoter in myeloid cells. Blood 88, 1234-1247.
47. Tanaka, T., Akira, S., Yoshida, K., Umemoto, M., Yoneda, Y., Shirafuji, N., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T. (1995) Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80, 353-361.
48. Zhang, D. E., Zhang, P., Wang, N. D., Hetherington, C. J., Darlington, G. J., Tenen, D. G. (1997) Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc. Natl. Acad. Sci. USA 94, 569-574.
49. Zhang, P., Iwasaki-Arai, J., Iwasaki, H., Fenyus, M. L., Dayaram, T., Owens, B. M., Shigematsu, H., Levantini, E., Huettner, C. S., Lekstrom-Himes, J. A., Akashi, K., Tenen, D. G. (2004) Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity 21, 853-863.
50. Wouters, B. J., Jorda, M. A., Keeshan, K., Louwers, I., Erpelinck-Verschueren, C. A., Tielemans, D., Langerak, A. W., He, Y., Yashiro-Ohtani, Y., Zhang, P., Hetherington, C. J., Verhaak, R. G., Valk, P. J., Lowenberg, B., Tenen, D. G., Pear, W. S., Delwel, R. (2007) Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. Blood 110, 3706-3714.
51. Classon, M., Harlow, E. (2002) The retinoblastoma tumour suppressor in development and cancer. Nat. Rev. Cancer 2, 910-917.
52. Dick, F. A., Rubin, S. M. (2013) Molecular mechanisms underlying RB protein function. Nat. Rev. Mol. Cell. Biol. 14, 297-306.
53. Hiebert, S. W., Chellappan, S. P., Horowitz, J. M., Nevins, J. R. (1992) The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6, 177-185.
54. Brown, V. D., Phillips, R. A., Gallie, B. L. (1999) Cumulative effect of phosphorylation of pRB on regulation of E2F activity. Mol. Cell. Biol. 19, 3246-3256.
55. Kastan, M. B., Bartek, J. (2004) Cell-cycle checkpoints and cancer. Nature 432, 316-323.